GalNT2 transgenic mouse with in vivo proteomics data for altered O-glycosylation residues
Anirban Maitra shared a post on X:
“This paper will be of interest to pancreas biologists.
A GalNT2 transgenic mouse with in vivo proteomics data for altered O-glycosylation residues.
No muKRAS crosses here.
GalNT2-mediated O-glycosylation affects pancreas development and function in mice
Authors: Baris Mercanoglu, Sissy-Alina Waschkowski, Elena Neuburg, Nina Schraps, Anastasios D. Giannou, Benjamin Dreyer, Sönke Harder, Markus Heine, Christian F. Krebs, Cenap Güngör, Hartmut Schlüter, Nathaniel Melling, Thilo Hackert, Maximilian Bockhorn, Christoph Wagener, Gerrit Wolters-Eisfeld.”
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023